Seiji HIRAKU

Pharmacological Studies on the TXA2 Synthetase Inhibitor (E)-3-[p(1H-lmidazol-1-Ylmethyl)Phenyl]-2-Propenoic Acid (OKY-046)

Seiji HIRAKU, Ken Taniguchi, Korekiyo Wakitani et al. · The Japanese Journal of Pharmacology · 1986 · 63 citations · Full text

Medicine, Pharmacology, Biochemical Pharmacology +12

Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.

Yoshiki Yui, Ryuichi Hattori, Yoshiki Takatsu et al. · Circulation · 1984 · 21 citations · Full text

Medicine, Pharmacology, Biochemical Pharmacology +8

Effect of Ozagrel on Locomotor and Motor Coordination after Transient Cerebral Ischemia in Experimental Animal Models

Kiyoshi Ichikawa, Shigeki Tazawa, Shuichiro Hamano et al. · Pharmacology · 1999 · 18 citations

Medicine, Neuroscience, Pharmacology +14

A highly sensitive and selective method for the determination of Leukotriene B4 in human plasma by negative ion chemical ionization/gas chromatography/tandem mass spectrometry

Mayumi Takamoto, Tomoko Yano, Tetsuya Shintani et al. · Journal of Pharmaceutical and Biomedical Analysis · 1995 · 15 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +6

Studies on the Metabolic Fate of Ultra Short Acting .BETA.1 Blocker ONO-1101. (3). Metabolism and Protein Binding.

Ken TSUNEKAWA, Haruo Imawaka, Katsuhiko Yamamoto et al. · Drug Metabolism and Pharmacokinetics · 1997 · 14 citations · Full text

Life Sciences, Biochemistry, Pharmacology +7